Concepedia

Kathrin Heinzmann

KH

Statistics

Publications

10

Citations

1.3K

H-Index

10

Active since

2008

Affiliations

Imperial College London(Current)

Cancer Research UK

University of Münster

Hammersmith Hospital

University of Manchester

Kathrin Heinzmann is an author at Imperial College London specializing in medicine, oncology, and bioinformatics.

ORCID

Top concepts

Publications per year

2008–2023

10

Publications

10

An empirical framework for binary interactome mapping

K. Venkatesan, Jean‐François Rual, Alexei Vázquez et al. · Nature Methods · 2008 · 899 citations · Full text

, , +8

A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer

Sarah Halford, Gareth J. Veal, Stephen R. Wedge et al. · Clinical Cancer Research · 2023 · 177 citations · Full text

AT13148 Is a Novel, Oral Multi-AGC Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity

Timothy A. Yap, Mike I. Walton, Kyla M. Grimshaw et al. · Clinical Cancer Research · 2012 · 90 citations · Full text

Clinical translation of [18F]ICMT-11 for measuring chemotherapy-induced caspase 3/7 activation in breast and lung cancer

Suraiya Dubash, Shairoz Merchant, Kathrin Heinzmann et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 42 citations · Full text

Phase I expansion study of the first-in-class monocarboxylate transporter 1 (MCT1) inhibitor AZD3965 in patients with diffuse large B-cell lymphoma (DLBCL) and Burkitt lymphoma (BL).

Sarah Halford, Harriet S. Walter, Pam McKay et al. · Journal of Clinical Oncology · 2021 · 34 citations · Full text

, , +18

Rows per page

1–5 of 10